Chronic inhibition of tumor cell-derived VEGF enhances the malignant phenotype of colorectal cancer cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic inhibition of tumor cell-derived VEGF enhances the malignant phenotype of colorectal cancer cells
Authors
Keywords
Vegf mRNA, Vegf Gene, Chronic Loss, Respective Control Cell
Journal
BMC CANCER
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-05-08
DOI
10.1186/1471-2407-13-229
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
- (2012) Kan V. Lu et al. CANCER CELL
- Hypoxia-Inducible Factors in Physiology and Medicine
- (2012) Gregg L. Semenza CELL
- Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system
- (2012) Henning Karlsson et al. EXPERIMENTAL CELL RESEARCH
- Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α
- (2012) Yeo-Jung Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Hypoxia inducible factor-1α is necessary for invasive phenotype in Vegf-deleted islet cell tumors
- (2012) Takaaki Takeda et al. Scientific Reports
- The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation
- (2011) Yukie Yoshii et al. BIOMATERIALS
- Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration
- (2011) F Fan et al. BRITISH JOURNAL OF CANCER
- VEGFR-1 Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Growth
- (2011) Natasha Y. Frank et al. CANCER RESEARCH
- Targeted therapy in renal cell carcinoma
- (2010) Bhanu K Vakkalanka et al. CURRENT OPINION IN UROLOGY
- Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells
- (2010) S Samuel et al. ONCOGENE
- Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited
- (2009) Sonja Loges et al. CANCER CELL
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy
- (2009) J. M. L. Ebos et al. CLINICAL CANCER RESEARCH
- RNA-binding proteins implicated in the hypoxic response
- (2009) Kiyoshi Masuda et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Differential Involvement of Vascular Endothelial Growth Factor in the Survival of Hypoxic Colon Cancer Cells
- (2008) M. Calvani et al. CANCER RESEARCH
- Pathways Mediating Resistance to Vascular Endothelial Growth Factor-Targeted Therapy
- (2008) L. M. Ellis et al. CLINICAL CANCER RESEARCH
- Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies
- (2008) Farbod Shojaei et al. DRUG RESISTANCE UPDATES
- Bevacizumab: direct anti-VEGF therapy in renal cell carcinoma
- (2008) Bernard Escudier et al. Expert Review of Anticancer Therapy
- A Novel Tumor-Promoting Function Residing in the 5′ Non-coding Region of vascular endothelial growth factor mRNA
- (2008) Kiyoshi Masuda et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search